What has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitis

Basit Öğe Kaydı
dc.authorwosidDemirel, Tugrul/JAC-3486-2023
dc.contributor.authorTurkyilmaz, Zeliha
dc.contributor.authorDemirel, Tugrul
dc.contributor.authorCakcak, Ibrahim Ethem
dc.contributor.authorAytin, Yusuf Emre
dc.date.accessioned2024-06-12T10:50:32Z
dc.date.available2024-06-12T10:50:32Z
dc.date.issued2023
dc.departmentTrakya Üniversitesien_US
dc.description.abstractBACKGROUND: The COVID-19 pandemic thoroughly changed the daily practices of medicine. We retrospectively evaluated the impact of the COVID-19 pandemic on our management strategies for patients with acute biliary pancreatitis (ABP).METHODS: A total of 91 patients with ABP who were treated at Trakya University Faculty of Medicine between March 15, 2019 and March 15, 2021 were retrospectively recruited. Patients were classified as pre-COVID and COVID-era patients. The comorbidity markers, data from laboratory tests, inflammatory markers, and radiological examinations were evaluated. Length of stay, need for an intensive care unit, morbidity, mortality, recurrent ABP, and definitive treatment rates were evaluated, and the data of the two periods were compared.RESULTS: Two groups of patients, 57 in the pre-COVID period and 34 in the COVID period, were included in the study. We found that ABP admissions decreased significantly during periods of increased national COVID-19 diagnoses. Type 2 diabetes mellitus was significantly higher in the COVID period patients (P=0.044), and COVID patients had significantly higher total (P=0.004), direct bilirubin (P=0.007), and lipases (P<0.001). The cholecystectomy rate after an attack decreased from 26% in the pre-COVID period toCONCLUSION: COVID strikingly reduced the admissions of ABP patients in the early stages of the disease to hospitals, leading to inevitable admissions in advanced severity. Moreover, a significant increase was detected in the recurrence rates of ABP. This can be explained by the reduction in cholecystectomy performed.en_US
dc.identifier.doi10.14744/tjtes.2023.06486
dc.identifier.endpage1174en_US
dc.identifier.issn1306-696X
dc.identifier.issn1307-7945
dc.identifier.issue10en_US
dc.identifier.pmid37791437en_US
dc.identifier.scopus2-s2.0-85175187162en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1167en_US
dc.identifier.urihttps://doi.org/10.14744/tjtes.2023.06486
dc.identifier.urihttps://hdl.handle.net/20.500.14551/18037
dc.identifier.volume29en_US
dc.identifier.wosWOS:001087012200014en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTurkish Assoc Trauma Emergency Surgeryen_US
dc.relation.ispartofUlusal Travma Ve Acil Cerrahi Dergisi-Turkish Journal Of Trauma & Emergency Surgeryen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAcute Biliary Pancreatitisen_US
dc.subjectCholecystectomyen_US
dc.subjectCOVID Eraen_US
dc.subjectCOVID-19en_US
dc.subjectSystemic Inflammatory Response Index.en_US
dc.subjectGallstone Pancreatitisen_US
dc.subjectCholecystectomyen_US
dc.subjectSphincterotomyen_US
dc.titleWhat has changed? The impact of the COVID-19 pandemic on the management of acute biliary pancreatitisen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu